US advisers decline to push Gardasil for boys
Source: Reuters.com Author: Maggie Fox * Committee advises that doctors free to use vaccine * Says needs more evidence of cost benefit * Did not consider value in preventing cancer (Updates throughout, adds quotes, share price) WASHINGTON, Oct 21 (Reuters) - U.S. vaccine advisers declined to press for the use of Merck & Co's (MRK.N) Gardasil in boys and men, opting instead on Wednesday to simply advise doctors they are free to use it. Despite some impassioned pleas from patients and doctors alike, the Advisory Committee on Immunization Practices voted almost unanimously for "permissive" use of the vaccine for boys. It protects against the human papillomavirus, or HPV, which causes a variety of cancers and genital warts. But the committee did recommend including Gardasil for eligible boys aged 9 to 18 in the Vaccines For Children program, a government-funded system that provides vaccines to children eligible for the state-federal Medicaid health insurance plan and other uninsured children. Merck's shares were down 1.7 percent at $33.16 in afternoon trading on the New York Stock Exchange. The U.S. Centers for Disease Control and Prevention currently recommends Gardasil for girls 11 and 12 years old and women 13 to 26 who have not been vaccinated. Earlier this month, the U.S. Food and Drug Administration approved Gardasil for preventing genital warts in boys and men ages 9 through 26. The main reason the vaccine was approved was to prevent cervical cancer, which kills 4,000 women a year in the United States alone. But various [...]